29583

    524654

    NATCAPSUQ

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NATURAL CAPSULES LIMITED Share Price Today

    NATURAL CAPSULES LIMITED is currently trading at ₹145, up by ₹2.88 from the previous close. The stock touched an intraday high of ₹148.56 and a low of ₹143.10 during the latest trading session. Over the past one year, NATURAL CAPSULES LIMITED has delivered a loss of 35.64%, while the stock has declined 10.53% in the last one month.

    NATURAL CAPSULES LIMITED performance

    Today’s low Today’s high
    ₹ 143.10 ₹ 148.56
    ₹ 145.00
    52 week low 52 week high
    ₹ 136.36 ₹ 296.00
    ₹ 145.00
    Open Price ₹ 144.50
    Prev. Close ₹ 142.11
    Volume (Shares) 3020.00
    Total traded value ₹ 4.37
    Upper Circuit ₹ 170.53
    Lower Circuit ₹ 113.69
    info

    Investment Returns

    Over 1 Month -10.53% Over 3 Months -7.88% Over 6 Months -26.28% Over 1 Year -35.64%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NATURAL CAPSULES LIMITED fundamentals


    • Market cap (Cr) 151.00
    • P/E Ratio (TTM) 13.09
    • Beta 0.36
    • Book Value / share 172.63
    • Return on equity 4.50%
    • EPS (TTM) 10.77
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) 146.80
    • P/E Ratio (TTM) 13.18
    • Beta 0.37
    • Book Value / share 172.63
    • Return on equity 4.50%
    • EPS (TTM) 10.77
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 5.52
    info icon alternate text

    NATURAL CAPSULES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 50.80
    Operating Expense 45.50
    Net Profit 5.52
    Net Profit Margin (%) 10.86
    Earnings Per Share (EPS) 5.33
    EBITDA 10.98
    Effective Tax Rate (%) 25.70
    Particulars DEC 2025 (Values in Cr)
    Revenue 34.15
    Operating Expense 35.79
    Net Profit 0.36
    Net Profit Margin (%) 1.05
    Earnings Per Share (EPS) 0.35
    EBITDA 4.00
    Effective Tax Rate (%) 21.73
    Particulars SEP 2025 (Values in Cr)
    Revenue 44.58
    Operating Expense 42.61
    Net Profit 2.81
    Net Profit Margin (%) 6.30
    Earnings Per Share (EPS) 2.72
    EBITDA 7.17
    Effective Tax Rate (%) 24.05
    Particulars JUN 2025 (Values in Cr)
    Revenue 44.24
    Operating Expense 42.46
    Net Profit 2.52
    Net Profit Margin (%) 5.69
    Earnings Per Share (EPS) 2.44
    EBITDA 6.83
    Effective Tax Rate (%) 27.29
    Particulars MAR 2025 (Values in Cr)
    Revenue 44.36
    Operating Expense 42.77
    Net Profit 2.63
    Net Profit Margin (%) 5.92
    Earnings Per Share (EPS) 2.17
    EBITDA 6.59
    Effective Tax Rate (%) 16.29
    Particulars MAR 2026 (Values in Cr)
    Revenue 173.77
    Operating Expense 166.35
    Net Profit 11.21
    Net Profit Margin (%) 6.45
    Earnings Per Share (EPS) 10.79
    EBITDA 28.98
    Effective Tax Rate (%) 25.54
    Particulars MAR 2025 (Values in Cr)
    Revenue 167.94
    Operating Expense 162.88
    Net Profit 6.71
    Net Profit Margin (%) 3.99
    Earnings Per Share (EPS) 6.12
    EBITDA 23.54
    Effective Tax Rate (%) 27.84
    Particulars MAR 2024 (Values in Cr)
    Revenue 153.81
    Operating Expense 146.56
    Net Profit 7.81
    Net Profit Margin (%) 5.07
    Earnings Per Share (EPS) 8.64
    EBITDA 23.91
    Effective Tax Rate (%) 24.92
    Particulars MAR 2023 (Values in Cr)
    Revenue 172.87
    Operating Expense 148.20
    Net Profit 19.20
    Net Profit Margin (%) 11.10
    Earnings Per Share (EPS) 20.63
    EBITDA 36.50
    Effective Tax Rate (%) 25.40
    Particulars MAR 2022 (Values in Cr)
    Revenue 135.07
    Operating Expense 116.57
    Net Profit 13.95
    Net Profit Margin (%) 10.32
    Earnings Per Share (EPS) 19.62
    EBITDA 26.43
    Effective Tax Rate (%) 28.20
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 225.25
    ROE % 0.28
    ROCE % 2.86
    Total Debt to Total Equity 0.49
    EBITDA Margin 10.90
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 218.39
    ROE % 3.39
    ROCE % 5.00
    Total Debt to Total Equity 0.63
    EBITDA Margin 14.15
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 132.85
    ROE % 17.89
    ROCE % 16.14
    Total Debt to Total Equity 0.73
    EBITDA Margin 20.84
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 118.34
    ROE % 19.18
    ROCE % 20.60
    Total Debt to Total Equity 0.43
    EBITDA Margin 19.63
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 99.63
    ROE % 8.94
    ROCE % 11.21
    Total Debt to Total Equity 0.14
    EBITDA Margin 14.86
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 160.83
    ROE % 4.50
    ROCE % 7.38
    Total Debt to Total Equity 0.40
    EBITDA Margin 14.12
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 141.30
    ROE % 6.10
    ROCE % 8.43
    Total Debt to Total Equity 0.44
    EBITDA Margin 15.64
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 133.74
    ROE % 18.54
    ROCE % 20.43
    Total Debt to Total Equity 0.40
    EBITDA Margin 21.30
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 118.45
    ROE % 19.22
    ROCE % 22.76
    Total Debt to Total Equity 0.30
    EBITDA Margin 19.65
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 99.68
    ROE % 9.00
    ROCE % 11.21
    Total Debt to Total Equity 0.14
    EBITDA Margin 14.90
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.28
    Total Assets 419.35
    Total Liabilities 419.35
    Total Equity 257.16
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 0.14
    Return on Capital (%) 0.17
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.33
    Total Assets 376.52
    Total Liabilities 376.52
    Total Equity 228.80
    Share Outstanding 0
    Price to Book Ratio 2.16
    Return on Assets (%) 1.47
    Return on Capital (%) 1.64
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.92
    Total Assets 288.76
    Total Liabilities 288.76
    Total Equity 148.24
    Share Outstanding 0
    Price to Book Ratio 2.94
    Return on Assets (%) 6.38
    Return on Capital (%) 7.54
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.88
    Total Assets 164.27
    Total Liabilities 164.27
    Total Equity 82.98
    Share Outstanding 0
    Price to Book Ratio 3.90
    Return on Assets (%) 8.46
    Return on Capital (%) 10.29
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.73
    Total Assets 97.04
    Total Liabilities 97.04
    Total Equity 62.09
    Share Outstanding 0
    Price to Book Ratio 1.08
    Return on Assets (%) 7.12
    Return on Capital (%) 9.64
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.70
    Total Assets 268.07
    Total Liabilities 268.07
    Total Equity 166.31
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 2.50
    Return on Capital (%) 3.03
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 9.24
    Total Assets 231.26
    Total Liabilities 231.26
    Total Equity 131.86
    Share Outstanding 0
    Price to Book Ratio 2.16
    Return on Assets (%) 3.37
    Return on Capital (%) 4.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.24
    Total Assets 210.39
    Total Liabilities 210.39
    Total Equity 124.05
    Share Outstanding 0
    Price to Book Ratio 2.94
    Return on Assets (%) 9.12
    Return on Capital (%) 11.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.98
    Total Assets 143.49
    Total Liabilities 143.49
    Total Equity 83.05
    Share Outstanding 0
    Price to Book Ratio 3.90
    Return on Assets (%) 9.72
    Return on Capital (%) 12.05
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.22
    Total Assets 96.65
    Total Liabilities 96.65
    Total Equity 62.13
    Share Outstanding 0
    Price to Book Ratio 1.08
    Return on Assets (%) 7.18
    Return on Capital (%) 9.68
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.79
    Cash from Operations 28.82
    Cash from Investing -44.48
    Cash from Financing 16.16
    Net change in Cash -1.56
    Free Cash Flow 73.45
    Particulars MAR 2024 (Values in Cr)
    Net Income 8.05
    Cash from Operations -6.38
    Cash from Investing -72.58
    Cash from Financing 81.71
    Net change in Cash 0.77
    Free Cash Flow 65.24
    Particulars MAR 2023 (Values in Cr)
    Net Income 24.99
    Cash from Operations 22.67
    Cash from Investing -104.62
    Cash from Financing 87.49
    Net change in Cash 0.07
    Free Cash Flow 128.56
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.38
    Cash from Operations 4.22
    Cash from Investing -45.87
    Cash from Financing 47.69
    Net change in Cash 1.30
    Free Cash Flow 48.55
    Particulars MAR 2021 (Values in Cr)
    Net Income 9.15
    Cash from Operations 14.81
    Cash from Investing -15.58
    Cash from Financing 2.75
    Net change in Cash -0.23
    Free Cash Flow 38.28
    Particulars MAR 2025 (Values in Cr)
    Net Income 9.29
    Cash from Operations 20.10
    Cash from Investing -34.37
    Cash from Financing 14.81
    Net change in Cash -1.52
    Free Cash Flow 22.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 10.39
    Cash from Operations 7.36
    Cash from Investing -10.83
    Cash from Financing 7.23
    Net change in Cash 1.79
    Free Cash Flow 15.34
    Particulars MAR 2023 (Values in Cr)
    Net Income 25.74
    Cash from Operations 25.55
    Cash from Investing -55.42
    Cash from Financing 34.44
    Net change in Cash -0.87
    Free Cash Flow 62.77
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.42
    Cash from Operations 9.83
    Cash from Investing -30.42
    Cash from Financing 26.51
    Net change in Cash 1.18
    Free Cash Flow 38.63
    Particulars MAR 2021 (Values in Cr)
    Net Income 9.19
    Cash from Operations 8.00
    Cash from Investing -8.53
    Cash from Financing 2.51
    Net change in Cash -0.23
    Free Cash Flow 24.42
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.10 12.90 1.50 238.33 23.12 38.85
    BLISS GVS PHARMA LTD 523.70 42.10 4.65 5554.16 118.35 552.90
    CIPLA LTD. 1441.70 30.60 3.38 116467.06 1165.55 1672.20
    FERMENTA BIOTECH LTD. 401.10 17.69 2.90 1180.48 256.40 414.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.10 21.75 4.00 238.33 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 535.25 23.99 4.17 1547.44 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8111.35 105.93 23.23 20278.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 523.70 56.62 4.80 5554.16 118.35 552.90

    NATURAL CAPSULES LIMITED shareholding pattern

    Holding
    48.95%
    51.04%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    NATURAL CAPSULES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    145.00 2.03 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 149.90
    • 26 Days 154.10
    • 10 Days 151.70
    • 50 Days 155.60
    • 12 Days 152.20
    • 100 Days 160.10
    • 20 Days 153.50
    • 200 Days 171.80
    142.49 PIVOT
    First Support 138.17 First Resistance 146.42 Second Support 134.24 Second Resistance 150.74 Third Support 129.92 Third Resistance 154.67
    RSI 40.45 ADX 23.12 MACD -1.93 Williams % R -84.68 Commodity Channel Index (CCI) -136.09
    Date 2026-07-09 Week 3399.00 Same Day 4715.00 Month 8045.00
    1 Year 0.37 3 Year 0.33
    Over 1 Month
    -10.53% down
    Over 1 Year
    -35.64% down
    Over 3 Months
    -7.88% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -26.28% down
    Over 5 Years
    0.00% down

    NATURAL CAPSULES LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
    09 Sep 2022 1.0 Final 13 Sep 2022 Equity shares
    06 Jul 2021 1.0 Final 08 Jul 2021 Equity shares
    12 Aug 2020 0.6 Final 14 Aug 2020 Equity shares
    13 Aug 2019 1.0 Final 15 Aug 2019 Equity shares
    12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
    18 Aug 2017 1.0 Final 22 Aug 2017 Equity shares
    16 Aug 2016 1.5 Final 19 Aug 2016 Equity shares
    19 Aug 2015 1.5 Final 21 Aug 2015 Equity shares
    20 Aug 2014 1.5 Final 22 Aug 2014 Equity shares
    19 Jul 2013 1.5 Final 23 Jul 2013 Equity shares
    20 Jul 2012 1.5 Final 24 Jul 2012 Equity shares
    21 Jul 2011 1.2 Final 23 Jul 2011 Equity shares
    23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
    23 Jul 2009 1.2 Final 27 Jul 2009 Equity shares
    24 Jul 2008 1.0 Final 26 Jul 2008 Equity shares
    20 Jul 2007 1.0 Final 24 Jul 2007 Equity shares
    21 Jul 2005 0.0 Final 23 Jul 2005 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
    09 Sep 2022 1.0 Final 13 Sep 2022 Equity shares
    06 Jul 2021 1.0 Final 08 Jul 2021 Equity shares
    12 Aug 2020 0.6 Final 14 Aug 2020 Equity shares
    13 Aug 2019 1.0 Final 15 Aug 2019 Equity shares
    12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
    18 Aug 2017 1.0 Final 22 Aug 2017 Equity shares
    16 Aug 2016 1.5 Final 19 Aug 2016 Equity shares
    19 Aug 2015 1.5 Final 21 Aug 2015 Equity shares
    20 Aug 2014 1.5 Final 22 Aug 2014 Equity shares
    19 Jul 2013 1.5 Final 23 Jul 2013 Equity shares
    20 Jul 2012 1.5 Final 24 Jul 2012 Equity shares
    21 Jul 2011 1.2 Final 23 Jul 2011 Equity shares
    23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
    23 Jul 2009 1.2 Final 27 Jul 2009 Equity shares
    24 Jul 2008 1.0 Final 26 Jul 2008 Equity shares
    20 Jul 2007 1.0 Final 24 Jul 2007 Equity shares
    21 Jul 2005 0.0 Final 23 Jul 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Natural Capsules Ltd?

    Answer Field

    Natural Capsules Ltd share price is for NSE ₹ 145.00 & for BSE ₹ 141.35 as on Jul 10 2026 03:12 PM.

    What is the Market Cap of Natural Capsules Ltd Share?

    Answer Field

    The market cap of Natural Capsules Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 10 2026 03:12 PM.

    What is the 52 Week High and Low of Natural Capsules Ltd?

    Answer Field

    The 52 Week High and Low of Natural Capsules Ltd for NSE is ₹ 296.00 and ₹ 136.36 and for BSE is ₹ 296.40 and ₹ 137.50.

    What is 1 year return for Natural Capsules Ltd?

    Answer Field

    The 1 year returns on the stock has been -35.64%.

    What is the P/E Ratio of Natural Capsules Ltd Share?

    Answer Field

    As on Jul 10 2026 03:12 PM the price-to-earnings (PE) ratio for Natural Capsules Ltd share is 13.09.

    What is the PB ratio of Natural Capsules Ltd Share?

    Answer Field

    As on Jul 10 2026 03:12 PM, the price-to-book (PB) ratio for Natural Capsules Ltd share is 172.63.

    How to Buy Natural Capsules Ltd Share?

    Answer Field

    You can trade in Natural Capsules Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Natural Capsules Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Natural Capsules Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Natural Capsules Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |